Comorbidities Don't Block Talk Therapy in Children

SEATTLE — The presence of a comorbid anxiety disorder in children with phobias does not interfere with the child's ability to respond to cognitive-behavioral therapy.

The children who responded to cognitive-behavioral therapy (CBT) were also able to reduce the symptoms of their comorbid disorders, according to data presented by Thomas H. Ollendick, Ph.D., at the annual meeting of the Anxiety Disorders Association of America.

“The presence of a comorbid anxiety disorder made no difference and did not interfere with the ability to treat,” reported Dr. Ollendick, in a poster presentation. “There was no difference as to the type of comorbidity, although we did exclude comorbid disorders such as autism and schizophrenia, which generally cause more severe impairment.”

The rates of comorbidity in children with anxiety are significant. But the impact of comorbidity on treatment efficacy is relatively unknown, and this area has not been well studied, said Dr. Ollendick, professor of psychology and director of the Child Study Center at Virginia Polytechnic Institute and State University in Blacksburg.

In fact, no studies have been undertaken looking at the influence of specific treatments on nontargeted comorbid conditions.

The investigators evaluated treatment efficacy in 105 children aged 7–16 years, who met the DSM-IV criteria for a specific phobia based on a pretreatment structured interview.

Within the group, 22.8% had a specific phobia (SP) only, 42.8% had an SP as their primary diagnosis and another untreated SP as a secondary diagnosis, 29.5% had a generalized anxiety disorder as a secondary diagnosis, 17.1% were diagnosed with comorbid separation anxiety disorder, 17.1% had comorbid social anxiety disorder, and 12.4% had comorbid attention-deficit hyperactivity disorder.

The primary diagnosis was the one causing the greatest interference and distress for the child, based on the Anxiety Disorders Interview Schedule, Child and Parent versions (ADIS-C/P).

The intensive CBT for specific phobias called “One Session Treatment,” included the techniques of in vivo exposure, participant modeling, social reinforcement, and cognitive restructuring in a single session.

Children with a specific phobia had a 62.5% response rate to CBT, compared with 53.8% of those with an accompanying comorbid anxiety disorder.

The study is ongoing, Dr. Ollendick said, but the numbers so far are robust.

SEATTLE — The presence of a comorbid anxiety disorder in children with phobias does not interfere with the child's ability to respond to cognitive-behavioral therapy.

The children who responded to cognitive-behavioral therapy (CBT) were also able to reduce the symptoms of their comorbid disorders, according to data presented by Thomas H. Ollendick, Ph.D., at the annual meeting of the Anxiety Disorders Association of America.

“The presence of a comorbid anxiety disorder made no difference and did not interfere with the ability to treat,” reported Dr. Ollendick, in a poster presentation. “There was no difference as to the type of comorbidity, although we did exclude comorbid disorders such as autism and schizophrenia, which generally cause more severe impairment.”

The rates of comorbidity in children with anxiety are significant. But the impact of comorbidity on treatment efficacy is relatively unknown, and this area has not been well studied, said Dr. Ollendick, professor of psychology and director of the Child Study Center at Virginia Polytechnic Institute and State University in Blacksburg.

In fact, no studies have been undertaken looking at the influence of specific treatments on nontargeted comorbid conditions.

The investigators evaluated treatment efficacy in 105 children aged 7–16 years, who met the DSM-IV criteria for a specific phobia based on a pretreatment structured interview.

Within the group, 22.8% had a specific phobia (SP) only, 42.8% had an SP as their primary diagnosis and another untreated SP as a secondary diagnosis, 29.5% had a generalized anxiety disorder as a secondary diagnosis, 17.1% were diagnosed with comorbid separation anxiety disorder, 17.1% had comorbid social anxiety disorder, and 12.4% had comorbid attention-deficit hyperactivity disorder.

The primary diagnosis was the one causing the greatest interference and distress for the child, based on the Anxiety Disorders Interview Schedule, Child and Parent versions (ADIS-C/P).

The intensive CBT for specific phobias called “One Session Treatment,” included the techniques of in vivo exposure, participant modeling, social reinforcement, and cognitive restructuring in a single session.

Children with a specific phobia had a 62.5% response rate to CBT, compared with 53.8% of those with an accompanying comorbid anxiety disorder.

The study is ongoing, Dr. Ollendick said, but the numbers so far are robust.

SEATTLE — The presence of a comorbid anxiety disorder in children with phobias does not interfere with the child's ability to respond to cognitive-behavioral therapy.

The children who responded to cognitive-behavioral therapy (CBT) were also able to reduce the symptoms of their comorbid disorders, according to data presented by Thomas H. Ollendick, Ph.D., at the annual meeting of the Anxiety Disorders Association of America.

“The presence of a comorbid anxiety disorder made no difference and did not interfere with the ability to treat,” reported Dr. Ollendick, in a poster presentation. “There was no difference as to the type of comorbidity, although we did exclude comorbid disorders such as autism and schizophrenia, which generally cause more severe impairment.”

The rates of comorbidity in children with anxiety are significant. But the impact of comorbidity on treatment efficacy is relatively unknown, and this area has not been well studied, said Dr. Ollendick, professor of psychology and director of the Child Study Center at Virginia Polytechnic Institute and State University in Blacksburg.

In fact, no studies have been undertaken looking at the influence of specific treatments on nontargeted comorbid conditions.

The investigators evaluated treatment efficacy in 105 children aged 7–16 years, who met the DSM-IV criteria for a specific phobia based on a pretreatment structured interview.

Within the group, 22.8% had a specific phobia (SP) only, 42.8% had an SP as their primary diagnosis and another untreated SP as a secondary diagnosis, 29.5% had a generalized anxiety disorder as a secondary diagnosis, 17.1% were diagnosed with comorbid separation anxiety disorder, 17.1% had comorbid social anxiety disorder, and 12.4% had comorbid attention-deficit hyperactivity disorder.

The primary diagnosis was the one causing the greatest interference and distress for the child, based on the Anxiety Disorders Interview Schedule, Child and Parent versions (ADIS-C/P).

The intensive CBT for specific phobias called “One Session Treatment,” included the techniques of in vivo exposure, participant modeling, social reinforcement, and cognitive restructuring in a single session.

Children with a specific phobia had a 62.5% response rate to CBT, compared with 53.8% of those with an accompanying comorbid anxiety disorder.

The study is ongoing, Dr. Ollendick said, but the numbers so far are robust.